JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.01% |
| 2 | Financials | 14.82% |
| 3 | Technology | 12.49% |
| 4 | Healthcare | 9.61% |
| 5 | Consumer Discretionary | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3326
iShares MSCI Malaysia ETF
EWM
$282M
| $1.52M | ﹤0.01% |
46,175
-42,017
| -48% | -$1.36M |
2013 Q2
18 quarters
|
|
3327
Farmers National Banc Corp
FMNB
$898M
| $1.52M | ﹤0.01% |
102,831
+331
| +0.3% | +$4.91K |
2015 Q4
8 quarters
|
|
3328
iShares Core 10+ Year USD Bond ETF
ILTB
$588M
| $1.51M | ﹤0.01% |
23,327
+5,895
| +34% | +$377K |
2014 Q3
13 quarters
|
|
|
CNBKA
3329
DELISTED
Century Bancorp Inc/Mass
CNBKA
| $1.51M | ﹤0.01% |
19,292
+3,963
| +26% | +$334K |
2013 Q2
18 quarters
|
|
3330
Upland Software
UPLD
$10.7M
| $1.5M | ﹤0.01% |
6,945
+3,978
| +134% | +$873K |
2017 Q2
2 quarters
|
|
3331
Digi International
DGII
$2.79B
| $1.5M | ﹤0.01% |
157,182
+30,939
| +25% | +$316K |
2015 Q1
11 quarters
|
|
3332
Abercrombie & Fitch
ANF
$5.79B
| $1.5M | ﹤0.01% |
86,029
-421,400
| -83% | -$6.4M |
2013 Q2
18 quarters
|
|
3333
Park-Ohio Holdings
PKOH
$674M
| $1.5M | ﹤0.01% |
32,601
-1,433
| -4% | -$64.2K |
2013 Q2
18 quarters
|
|
3334
iShares US Utilities ETF
IDU
$1.33B
| $1.5M | ﹤0.01% |
22,538
-1,054
| -4% | -$72.5K |
2013 Q2
18 quarters
|
|
3335
UNIFI
UFI
$121M
| $1.5M | ﹤0.01% |
41,732
+23,039
| +123% | +$833K |
2013 Q2
18 quarters
|
|
3336
Vanguard Morningstar Large-Cap ETF
VV
$54.1B
| $1.49M | ﹤0.01% |
12,166
+391
| +3% | +$46.7K |
2013 Q2
18 quarters
|
|
|
AVEO
3337
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $1.49M | ﹤0.01% |
+53,453
| New | +$1.66M |
2017 Q4
0 quarters
|
|
3338
VanEck Fallen Angel High Yield Bond ETF
ANGL
$3.07B
| $1.49M | ﹤0.01% |
49,658
+778
| +2% | +$23.4K |
2016 Q2
6 quarters
|
|
3339
iShares Semiconductor ETF
SOXX
$49.1B
| $1.49M | ﹤0.01% |
26,274
+2,832
| +12% | +$161K |
2015 Q2
10 quarters
|
|
|
MOBL
3340
DELISTED
MobileIron, Inc.
MOBL
| $1.48M | ﹤0.01% |
380,407
+94,312
| +33% | +$364K |
2016 Q4
4 quarters
|
|
3341
Usana Health Sciences
USNA
$266M
| $1.48M | ﹤0.01% |
19,941
+2,501
| +14% | +$167K |
2013 Q2
18 quarters
|
|
3342
iShares Core Moderate Allocation ETF
AOM
$1.88B
| $1.48M | ﹤0.01% |
38,784
+36,599
| +1,675% | +$1.4M |
2016 Q2
6 quarters
|
|
3343
Artivion
AORT
$1.07B
| $1.47M | ﹤0.01% |
76,868
+24,726
| +47% | +$495K |
2016 Q2
6 quarters
|
|
|
LEXEA
3344
DELISTED
Liberty Expedia Holdings, Inc. Class A Common Stock
LEXEA
| $1.47M | ﹤0.01% |
33,136
-93,552
| -74% | -$4.49M |
2016 Q4
4 quarters
|
|
3345
Capitol Federal Financial
CFFN
$1.04B
| $1.47M | ﹤0.01% |
109,469
+6,609
| +6% | +$92.7K |
2013 Q2
18 quarters
|
|
|
CIR
3346
DELISTED
CIRCOR International, Inc
CIR
| $1.47M | ﹤0.01% |
30,141
+206
| +0.7% | +$10.1K |
2016 Q4
4 quarters
|
|
3347
Seneca Foods Class A
SENEA
$1.2B
| $1.47M | ﹤0.01% |
47,676
-147
| -0.3% | -$4.87K |
2013 Q2
18 quarters
|
|
3348
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.9B
| $1.46M | ﹤0.01% |
11,747
-80
| -0.7% | -$9.88K |
2013 Q2
18 quarters
|
|
|
MRO
3349
CALL
DELISTED
Marathon Oil Corporation
MRO
| $1.46M | ﹤0.01% |
+86,400
| New | +$1.28M |
2017 Q4
0 quarters
|
|
3350
AeroVironment
AVAV
$7.13B
| $1.46M | ﹤0.01% |
25,999
+17,774
| +216% | +$905K |
2016 Q3
5 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 812 new, 2,513 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 812 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.